Request Deal Involvement

CVC Capital completed the acquisition of the international women's health assets from Teva for $703m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

RBC Capital Markets

financial advisors

RBC Capital Markets

Jefferies & Company

financial advisors

Jefferies & Company

Latham & Watkins

legal advisors

Latham & Watkins

Rothschild & Co

financial advisors

Rothschild & Co

Barclays

financial advisors

Barclays

Jones Day

legal advisors

Jones Day

Goodwin Procter

legal advisors

Goodwin Procter

Morgan Stanley

financial advisors

Morgan Stanley

Ernst & Young

accounting advisors

Ernst & Young

or

Principals

TEVA (INTERNATIONAL WOMEN'S HEALTH ASSETS)

target

TEVA (INTERNATIONAL WOMEN'S HEALTH ASSETS)

CVC CAPITAL PARTNERS

bidder

CVC CAPITAL PARTNERS

TEVA PHARMACEUTICALS

vendor

TEVA PHARMACEUTICALS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - CVC Capital completed the acquisition of the international women's health assets from Teva for $703m.